News About: Pharm. Industry
Novartis Korea CEO Hak-sun Moon on the waiting listCEO Hak-sun Moon at Novartis Korea which received search and seizure from the prosecution for suspicion of rebate provision this February was confirmed to be placed on the waiti...
|
‘Shocking’ investigation result of largest-scale illegal rebates of KRW 5.6 billion
The investigation result of the largest-scale pharmaceutical rebate incident has shocked the industry.
On the 12th, the Food and Drug Crime Department(Chief Prosecutor Cheol-hyung Byun) at the Seoul Western District...
Pharmaceutical industry complains, “Kim Young-Ran Act restricts us from holding any event”
The pharmaceutical industry also indicated the ‘Enforcement of the Act on Unlawful Request and Acceptance of Money and Valuables,’ also known as the ‘Kim Young-Ran Act,’ is a regulation that is hard to be taken realis...
Pharmaceutical industry in state of tension from illegal rebate investigations
Since the investigation result of the prosecution on a medium-sized pharmaceutical company(company P) for illegal rebates was announced, the pharmaceutical industry has been in a state of tension.
This is because th...
Weakened profitability of top pharmaceutical companies causes falls in stock price
It is disappointing to see the top pharmaceutical companies’ stock flow based on their sales. The leading pharmaceutical stock, Hanmi Pharm, was recorded at KRW 574 thousand as of the 9th, decreased by 20% in 3 months...
Pfizer’s counterattack against 13 domestic companiesPfizer which successfully protected the ‘Lyrica’ use patent started to counterattack. It has continued lawsuits against domestic companies which launched generics.
Pfizer Phar...
|
Green Cross’s ‘Rixubis’ enters domestic hemophilia B marketThe Green Cross and Baxalta alliance will target the hemophilia B market.
According to the industry concerned on the 9th, Green Cross will take in charge of domestic distribut...
|
Pharmaceutical Korea Wave in Middle East, starting in Iran
The domestic pharmaceutical industry which participated in the President Guen-hye Park’s state visit to Iran as the economic delegation has accelerated the target to the Middle Eastern market, such as a series of expo...
Weakened profitability is ‘labor pain to become global pharmaceuticals’
Some of the top pharmaceutical companies have been weakened in profitability due to active expansion of investments in R&D.
According to the pharmaceutical industry, triggered by the Hanmi Pharm’s successful cases, t...
Dong-A ST’s Stillen & Zydena decreased, Motilitone increased on 1st quarterOn the 2nd, Dong-A ST announced it recorded KRW 146.9 billion sales increased by 5.3%, KRW 11.7 billion profits decreased by 8.5% and KRW 4.5 billion net profits decreased by 48...
|
